Salomon & Ludwin’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Salomon & Ludwin’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.33K	Hold	100	–	–	﹤0.01%	1751
2026 Q1	$5.35K	Hold	100	–	–	﹤0.01%	1748
2025 Q4	$4.9K	Hold	100	–	–	﹤0.01%	1788
2025 Q3	$3.98K	Hold	100	–	–	﹤0.01%	1814
2025 Q2	$3.06K	Hold	100	–	–	﹤0.01%	614
2025 Q1	$2.85K	Hold	100	–	–	﹤0.01%	563
2024 Q4	$3.3K	Hold	100	–	–	﹤0.01%	548
2024 Q3	$3.73K	Hold	100	–	–	﹤0.01%	552
2024 Q2	$3.36K	Hold	100	–	–	﹤0.01%	561
2024 Q1	$3.58K	Hold	100	–	–	﹤0.01%	669
2023 Q4	$2.72K	Hold	100	–	–	﹤0.01%	636
2023 Q3	$2.72K	Buy	+100	New	+$3.01K	﹤0.01%	634

Other funds holding SBIO

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Salomon & Ludwin's SBIO Position: Q2 2026 in Review

Salomon & Ludwin held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q2 2026 at 100 shares worth $6.33K. The position accounts for ﹤0.01% of the portfolio, ranked #1751.

Salomon & Ludwin first reported a position in SBIO in Q3 2023 and has held it in 12 quarters since. 65 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

Salomon & Ludwin held 100 shares of ALPS Medical Breakthroughs ETF worth $6.33K as of Q2 2026.
Salomon & Ludwin left its ALPS Medical Breakthroughs ETF share count unchanged in Q2 2026.
ALPS Medical Breakthroughs ETF made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1751 holding.
Salomon & Ludwin first reported a position in ALPS Medical Breakthroughs ETF in Q3 2023 and has held it in 12 quarters since.
65 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.